The crosstalk between dendritic cells, cytokine-induced killer cells and cancer cells from the perspective of combination therapy
Dendritic cells (DCs) are considered the most potent professional antigen-presenting cells (APCs) that elicit adaptive antitumour immunity. DCs integrate multiple environmental signals by efficiently processing tumour-associated antigens (TAAs) and migrating to draining lymph nodes (dLNs), where the...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Limited liability company «Science and Innovations» (Saratov)
2021-06-01
|
| Series: | Russian Open Medical Journal |
| Subjects: | |
| Online Access: | https://romj.org/node/374 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849735498474455040 |
|---|---|
| author | Assel Issabekova Marzhan Zhumabekova Madina Zhunussova Vyacheslav Ogay |
| author_facet | Assel Issabekova Marzhan Zhumabekova Madina Zhunussova Vyacheslav Ogay |
| author_sort | Assel Issabekova |
| collection | DOAJ |
| description | Dendritic cells (DCs) are considered the most potent professional antigen-presenting cells (APCs) that elicit adaptive antitumour immunity. DCs integrate multiple environmental signals by efficiently processing tumour-associated antigens (TAAs) and migrating to draining lymph nodes (dLNs), where they present foreign antigens to T cells for priming. DCs thus serve as a major link between innate and adaptive immunity. Although DCs (mostly monocyte-derived DCs [mo-DCs]) have already been used in cancer therapies, such approaches have shown limited efficacy. Mo-DCs have the unique ability to present antigens to T cells in peripheral tissues. CD3+CD56+ cytokine-induced killer (CIK) cells are characterized by both MHC-restricted and MHC-unrestricted antitumour cytotoxicity against a broad range of cancer cells. This review presents an overview of the mechanisms by which mo-DCs and CIK cells’ interact with each other and with tumours.
The maturation of DCs was identified as a crucial step in the development of effective DC-based vaccines against cancer. A further improved adoptive immunotherapy strategy involves a combination of mature mo-DCs and CIK cells. Combination therapy presents many opportunities for cancer treatment, as reported by a number of clinical trials. However, there is a lack of fundamental studies on the interaction of in vitro-generated mo-DCs with CIK cells.
We discuss several methods of boosting DC-based vaccines and review the current knowledge of contact-dependent and cytokine-induced interactions of mo-DCs with CIK cells. We highlight that the combination of mo-DCs with CIK cells activates MHC-restricted and MHC-unrestricted immune responses. |
| format | Article |
| id | doaj-art-c736bcc77e3d42f1955f2d2e7249fb1b |
| institution | DOAJ |
| issn | 2304-3415 |
| language | English |
| publishDate | 2021-06-01 |
| publisher | Limited liability company «Science and Innovations» (Saratov) |
| record_format | Article |
| series | Russian Open Medical Journal |
| spelling | doaj-art-c736bcc77e3d42f1955f2d2e7249fb1b2025-08-20T03:07:33ZengLimited liability company «Science and Innovations» (Saratov)Russian Open Medical Journal2304-34152021-06-01102e020910.15275/rusomj.2021.0209The crosstalk between dendritic cells, cytokine-induced killer cells and cancer cells from the perspective of combination therapyAssel IssabekovaMarzhan ZhumabekovaMadina ZhunussovaVyacheslav OgayDendritic cells (DCs) are considered the most potent professional antigen-presenting cells (APCs) that elicit adaptive antitumour immunity. DCs integrate multiple environmental signals by efficiently processing tumour-associated antigens (TAAs) and migrating to draining lymph nodes (dLNs), where they present foreign antigens to T cells for priming. DCs thus serve as a major link between innate and adaptive immunity. Although DCs (mostly monocyte-derived DCs [mo-DCs]) have already been used in cancer therapies, such approaches have shown limited efficacy. Mo-DCs have the unique ability to present antigens to T cells in peripheral tissues. CD3+CD56+ cytokine-induced killer (CIK) cells are characterized by both MHC-restricted and MHC-unrestricted antitumour cytotoxicity against a broad range of cancer cells. This review presents an overview of the mechanisms by which mo-DCs and CIK cells’ interact with each other and with tumours. The maturation of DCs was identified as a crucial step in the development of effective DC-based vaccines against cancer. A further improved adoptive immunotherapy strategy involves a combination of mature mo-DCs and CIK cells. Combination therapy presents many opportunities for cancer treatment, as reported by a number of clinical trials. However, there is a lack of fundamental studies on the interaction of in vitro-generated mo-DCs with CIK cells. We discuss several methods of boosting DC-based vaccines and review the current knowledge of contact-dependent and cytokine-induced interactions of mo-DCs with CIK cells. We highlight that the combination of mo-DCs with CIK cells activates MHC-restricted and MHC-unrestricted immune responses.https://romj.org/node/374dendritic cellscytokine-induced killer cellsdendritic cells maturationheat-shock proteinsccr5 signalling |
| spellingShingle | Assel Issabekova Marzhan Zhumabekova Madina Zhunussova Vyacheslav Ogay The crosstalk between dendritic cells, cytokine-induced killer cells and cancer cells from the perspective of combination therapy Russian Open Medical Journal dendritic cells cytokine-induced killer cells dendritic cells maturation heat-shock proteins ccr5 signalling |
| title | The crosstalk between dendritic cells, cytokine-induced killer cells and cancer cells from the perspective of combination therapy |
| title_full | The crosstalk between dendritic cells, cytokine-induced killer cells and cancer cells from the perspective of combination therapy |
| title_fullStr | The crosstalk between dendritic cells, cytokine-induced killer cells and cancer cells from the perspective of combination therapy |
| title_full_unstemmed | The crosstalk between dendritic cells, cytokine-induced killer cells and cancer cells from the perspective of combination therapy |
| title_short | The crosstalk between dendritic cells, cytokine-induced killer cells and cancer cells from the perspective of combination therapy |
| title_sort | crosstalk between dendritic cells cytokine induced killer cells and cancer cells from the perspective of combination therapy |
| topic | dendritic cells cytokine-induced killer cells dendritic cells maturation heat-shock proteins ccr5 signalling |
| url | https://romj.org/node/374 |
| work_keys_str_mv | AT asselissabekova thecrosstalkbetweendendriticcellscytokineinducedkillercellsandcancercellsfromtheperspectiveofcombinationtherapy AT marzhanzhumabekova thecrosstalkbetweendendriticcellscytokineinducedkillercellsandcancercellsfromtheperspectiveofcombinationtherapy AT madinazhunussova thecrosstalkbetweendendriticcellscytokineinducedkillercellsandcancercellsfromtheperspectiveofcombinationtherapy AT vyacheslavogay thecrosstalkbetweendendriticcellscytokineinducedkillercellsandcancercellsfromtheperspectiveofcombinationtherapy AT asselissabekova crosstalkbetweendendriticcellscytokineinducedkillercellsandcancercellsfromtheperspectiveofcombinationtherapy AT marzhanzhumabekova crosstalkbetweendendriticcellscytokineinducedkillercellsandcancercellsfromtheperspectiveofcombinationtherapy AT madinazhunussova crosstalkbetweendendriticcellscytokineinducedkillercellsandcancercellsfromtheperspectiveofcombinationtherapy AT vyacheslavogay crosstalkbetweendendriticcellscytokineinducedkillercellsandcancercellsfromtheperspectiveofcombinationtherapy |